Priyanka Mehta

14PUBLICATIONS
76CO-AUTHORS
HaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 14, 2026
A Delphi Consensus on Optimising the Care Pathway for Adult Patients With Acute Myeloid Leukaemia (AML): Strategies to Enhance Transplant Accessibility and Feasibility in the United Kingdom.

|Jun 25, 2026
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial.

|Nov 14, 2025
CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.

Steven Knapper, Laura W Dillon, Malavika Babu

|Feb 06, 2025
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Adriano Venditti, Raffaele Palmieri, Luca Maurillo

|Nov 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial.

Nigel H Russell, Abin Thomas, Robert K Hills

|Jul 08, 2024
CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK.

Priyanka Mehta, Victoria Campbell, Jamie Maddox

Pageof 3

Frequent Collaborators

6 joint publications

Steven Knapper

6 joint publications

Sylvie Freeman

4 joint publications

Abin Thomas

4 joint publications

Richard Dillon